Thomas D. Boyer, MD

Professor, Medicine
Director, Arizona Liver Research Institute

Arizona Health Sciences 6309c
P.O. Box 245136
Tucson, AZ 85724-5136

Phone: 
(520) 626-5952
Email Address: 
tboyer@ahsc.arizona.edu
Education: 
  • University of Redlands, 1965 (B.S.)
  • University of Southern California, 1969 (M.D.)
  • Internal Medicine, University of Southern California, 1971 (Residency)
  • Internal Medicine, University of Southern California, 1974(Residency)
  • Liver Disease, University of Southern California, 1976 (Fellowship)
  • Gastroenterology, University of California San Francisco, 1978 (Fellowship)
Major Areas of Research Interest: 
  • hepatology
  • viral hepatitis
  • liver hemorrhage
  • liver transplantation
  • gastroenterology, internal medicine
Selected Publications: 

Whalen R. Liu X. Boyer TD. Identification of a short form of ubiquitin-specific protease 3 that is a repressor of rat glutathione S-transferase gene expression. Biochemical Journal. 394(Pt 2):519-26, 2006 .

Combes B. Emerson SS. Flye NL. Munoz SJ. Luketic VA. Mayo MJ. McCashland TM. Zetterman RK. Peters MG. Di Bisceglie AM. Benner KG. Kowdley KV. Carithers RL Jr. Rosoff L Jr. Garcia-Tsao G. Boyer JL. Boyer TD. Martinez EJ. Bass NM. Lake JR. Barnes DS. Bonacini M. Lindsay KL. Mills AS. Markin RS. Rubin R. West AB. Wheeler DE. Contos MJ. Hofmann AF. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology. 42(5):1184-93, 2005.

Boyer TD. Haskal ZJ. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. Journal of Vascular & Interventional Radiology. 16(5):615-29, 2005.

Ranganathan PN. Whalen R. Boyer TD. Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes. Biochemical Journal. 386(Pt 3):525-33, 2005.

Boyer TD. Haskal ZJ. American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 41(2):386-400, 2005.

Adams PC. Arthur MJ. Boyer TD. DeLeve LD. Di Bisceglie AM. Hall M. Levin TR. Provenzale D. Seeff L. Screening in liver disease: report of an AASLD clinical workshop. Hepatology. 39(5):1204-12, 2004.

Sponsored Research Through MSRP: 

Jeffrey Lambert (MSRP 2003): "A multicenter, randomized, double-blind, placebo-controlled parallel study to determine the efficacy and safety of pravastin 80 mg administered once daily to hypercholesterolemic subjects with chronic, well compensated liver disease." and " Investigation of neuropeptides involved in Alzheimer dementia and schizophrenia."

Jaskanwal Singh (MSRP 2006, 2007): "DNA Binding Region of Ubiquitin Specific Protease 3; 2007: DNA Binding Site of USP3 (Ubiquitin Specific Protease 3)."

NIH High School Student Research Program: 

-Sarahi Gigato, Pueblo High School, 2002

Last Updated: 
November 18, 2015